Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

  • This share is currently suspended. It was suspended at a price of 13.60

Share Price Information for Clean Power Hyd (CPH2)

Share Price is delayed by 15 minutes
Get Live Data
13.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £68.27m
CPH2 Live PriceLast checked at - London Stock Exchange

Intraday Clean Power Hyd Share Chart

Site Acceptance Test for MFE110 electrolyser

7 May 2025 11:23

RNS Number : 7056H
Clean Power Hydrogen
07 May 2025
 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

7 May 2025

 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

 

Successful Completion of Site Acceptance Test for MFE110 electrolyser

 

'MFE electrolyser working at scale on a customer site for the first time'

 

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that Level 3 of the Site Acceptance Test ("SAT") for its MFE110 electrolyser at Northern Ireland Water's ("NIW") site in Belfast has been successfully completed.

 

Highlights

· A pivotal milestone for CPH2 in commercialising its technology, with the MFE technology working at scale on a customer site for the first time, producing high purity hydrogen and oxygen in a commercial environment.

· Final stage of the SAT completed and independently witnessed by Lagan MEICA Limited ("Lagan"), the principal contractor, and ARUP, representing NIW.

· SAT demonstrated the MFE110 producing high purity hydrogen of 99.999mol% over prolonged period and 99.7wt% oxygen. Hydrogen generated is at fuel cell grade purity (ISO 14687)

· Signifies Northern Ireland's first production of pure hydrogen and oxygen generated reliably by an electrolyser at scale, a key market for CPH2.

· The milestone will help to unlock significant opportunities for NIW's decarbonisation efforts, as well as highlight the transformative potential of high purity oxygen across the wider wastewater treatment industry.

· Significant achievement in the safety case, demonstrating compliance with health and safety requirements for deploying an electrolyser within a public utility.

 

The final stage of the SAT for the MFE110 involved successfully verifying the safe and fully automated startup, operation, performance, and shutdown of the unit to the pre-determined specification at NIW site. The test was undertaken by Lagan, the contractor to NIW, and was overseen by engineering design specialists, Arup. SAT Level 3 followed successful pre-commissioning checks (Level 1) and functional tests (Level 2) at NIW's site. The MFE110 will play an important role in NIW's efforts to decarbonise its operations and explore transformational potential high purity oxygen in wastewater treatment.

 

The SAT of the MFE110 has demonstrated positive operational data with high purity of hydrogen at 99.999mol% over a prolonged period. The results provide confidence in the engineering capabilities of CPH2's technology and place the Group in a strong position as it advances the final design and build of the MFE220.

 

The successful test is a significant milestone for CPH2 and paves the way toward full commercialisation. It marks the first time CPH2's scaled MFE technology has been fully operational and functioning at a customer's site, providing further validation that MFE technology works at scale as the company progresses with the build of the first flagship MFE220 1MW system.

 

Strategic context of the MFE110 SAT

The success of the MFE110, culminating in the recent SAT, has provided valuable insights for developing CPH2's flagship MFE220, a 1MW system. Work is already underway on the final design and build, with Factory Acceptance Testing of the first MFE220 unit expected in H2 2025.

 

The Company has now entered its Commerciality Phase, focusing on key near-term milestones - delivering MFE220 units for its existing customer contracts, activating and supporting licensees, growing the commercial pipeline and continued technology and product improvement.

 

Jon Duffy, CEO of CPH2 commented:

"We are delighted that the MFE110 has successfully completed the final SAT level and that we now have a fully-fledged operational unit in the field. Our customer producing hydrogen and oxygen at its site using our scaled MFE technology is a significant milestone and proves that our technology is a current solution to green hydrogen production.

 

It is a strong start to our next phase of commercialisation, with the team now laser-focused on advancing the MFE220. We appreciate the guidance and support from Lagan MEICA Ltd and are incredibly grateful to our customer Northern Ireland Water, recipient of the Company's first MFE110, for their unwavering support and patience."

 

Alistair Jinks, Director of Business Services at Northern Ireland Water, commented:

"I am extremely pleased to have reached the successful conclusion of the SAT at our site in Belfast as we sit proudly with the first operational scaled MFE electrolyser in the country. While we have always taken pride in having a pioneering approach to sustainable water management, to have our vision become a reality is a special moment as we contribute to the hydrogen economy in Northern Ireland. We look forward to continuing our relationship with CPH2 and continuing to push the boundaries of the transformative potential of hydrogen and oxygen in wastewater treatment."

 

 

 

ENDS

 

 

For more information, please contact:

 

Clean Power Hydrogen plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3 757 4980

Owen Roberts

Kirsty Duff

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBDLFBEELLBBF
Date   Source Headline
5th Jun 20269:00 amRNSOperational Update
29th May 20267:30 amRNSSuspension - Clean Power Hydrogen PLC
29th May 20267:00 amRNS1MW MFE220 Factory Acceptance Test update
27th Apr 20267:00 amRNSMemorandum of Understanding with ABE GRUPPE GmbH
7th Apr 20267:00 amRNSMemorandum of Understanding with Koch Modular
30th Mar 20267:00 amRNSOperations & Trading Update
24th Mar 20267:00 amRNSMemorandum of Understanding with Siemens
19th Feb 20267:00 amRNS-RInvestor Webinar
29th Jan 20267:00 amRNSAppointment of Joint Broker
18th Dec 20257:00 amRNSSignificant Milestones Delivered
5th Nov 20257:00 amRNS-RMello2025 Investor Event
24th Oct 20257:00 amRNSAward under Salary Sacrifice Scheme
3rd Oct 20257:00 amRNSAward under the Company’s Long-Term Incentive Plan
30th Sep 20257:00 amRNSInterim Results
26th Sep 20257:00 amRNSAppointment of Chief Operations Director
26th Sep 20257:00 amRNSTR-1: Notification of major holdings
24th Sep 20253:58 pmRNSTR-1: Notification of major holdings
24th Sep 20253:48 pmRNSTR-1: Notification of major holdings
24th Sep 20253:48 pmRNSTR-1: Notification of major holdings
24th Sep 20253:44 pmRNSTR-1: Notification of major holdings
24th Sep 20253:41 pmRNSTR-1: Notification of major holdings
18th Sep 202512:26 pmRNSResult of General Meeting and Total Voting Rights
4th Sep 20257:00 amRNSResults of Oversubscribed Retail Offer
28th Aug 20254:35 pmRNSRetail Offer to Raise up to £300,000
28th Aug 20254:13 pmRNSResult of Placing and Subscription
28th Aug 20257:00 amRNSProposed Placing, Subscription, and Retail Offer
31st Jul 20257:00 amRNSCorporate Update and Proposed Fundraising
1st Jul 20257:00 amRNSWastewater Treatment Efficiency Gains
27th Jun 20257:00 amRNSManufacturing Partnership with Kenera
23rd Jun 20257:00 amRNSLicenced Manufacturing Partnership with Hidrigin
19th Jun 20251:08 pmRNSResult of AGM
16th Jun 20257:00 amRNSMemorandum of Understanding with Constant Energy
5th Jun 20257:00 amRNS2025 Save as You Earn Scheme
30th May 20257:00 amRNSAwards under the Long-Term Incentive Plan
21st May 20257:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20257:00 amRNS-RLongspur Research initiates coverage on CPH2
7th May 202511:23 amRNSSite Acceptance Test for MFE110 electrolyser
1st May 20257:00 amRNSFinal Results
22nd Apr 20257:00 amRNSNotice of Results
22nd Apr 20257:00 amRNSAppointment of Chief Commercial Officer
12th Mar 20257:00 amRNSLevel 2 of Site Acceptance Test Completed
24th Feb 20257:00 amRNSLevel 1 of Site Acceptance Test Completed
16th Jan 20259:21 amRNSIssue of Ordinary Shares
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.